This requirement of ATP for the activation of the inflammasome downstream of TLR2 but not TLR4 signaling might provide another explanation for the specific disease-promoting effects of the BLM receptor TLR2 in the model of BLM model that is not observed in the chronic WTI model. This evidence concerns the gene TLR2 and Bloom syndrome.